Announcement on Progress in Participating in Setting up Private Equity Investment Fund
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Progress in Participating in Setting up Private Equity Investment Fund
Filed with SSE · · 11 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-progress-in-participating-in-setting-up-private-equity-investment-fund
Release
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. on 6ix
Earlier from Shanghai Fosun Pharmaceutical (Group)
- Announcement on Outward Investment and Related Party Transactions
- Announcement on Holding Subsidiary’s Drug Obtaining Approval for Clinical Trial
- Announcement on Acceptance of Drug Registration Application of Holding Subsidiary
- Notice on Convening the 2025 Annual General Meeting, the 2nd A-Share Shareholders' Meeting in 2026, and the 2nd H-Share Shareholders' Meeting in 2026
- Announcement on Holding Subsidiary’s Drug Obtaining Approval for Clinical Trial from FDA
Later from Shanghai Fosun Pharmaceutical (Group)
- Announcement on Obtaining Approval of Drug Registration by the Holding Subsidiary
- Announcement on New Drug Indication Obtaining Registration Approval for a Holding Subsidiary
- Announcement on Holding Subsidiary's Passing GMP Compliance Inspection
- Announcement on Progress in Providing Guarantee for Holding Subsidiary
- Indicative Announcement on Obtaining EU Approval of a New Indication for a Drug Developed by the Holding Subsidiary
Follow Shanghai Fosun Pharmaceutical (Group) into a list and get an email when it puts out news.
Follow Shanghai Fosun Pharmaceutical (Group)